Masimo Corp

Masimo Corp develops and markets noninvasive patient monitoring technologies, hospital automation and connectivity solutions, and remote monitoring devices for healthcare settings. The company sells through direct sales, distributors, and OEM partners, with products used to measure patient status in hospitals, EMS, home care, physician offices, veterinary, and long-term care settings.

22,8 %

61,9 %

−9,9 %

2.49

1.47

— Masimo Corp
	%
Patient monitoring systems	45% Core hospital and clinical monitoring platforms used to track patient status noninvasively.
Sensors and consumables	30% Single-patient-use and reusable sensors and related consumables used with monitoring devices.
Hospital automation and connectivity	10% Workflow, connectivity, and integration solutions for hospital environments.
Remote monitoring and home care	8% Devices and solutions used outside acute care, including home care and long-term care.
OEM and partner channel products	7% Monitoring technologies sold through OEM partners and distributor relationships.

Masimo sells primarily to healthcare providers and channel partners that need reliable patient monitoring and workflow...

Hospitals and health systemsprimary
Buy monitoring platforms, sensors, and connectivity tools to support bedside care and workflow efficiency.
OEM partnersprimary
Integrate Masimo technology into third-party devices and platforms to broaden market access.
Distributors and just-in-time distributorsprimary
Purchase and resell products, including tender-driven and international orders, to extend commercial reach.
EMS, home care, and long-term care providerssecondary
Buy remote and portable monitoring solutions for non-acute and mobile care settings.
Physician offices and veterinarianssecondary
Purchase point-of-care monitoring products for smaller clinical and specialty-use settings.

Masimo is described as a global technology company, and its revenue includes foreign sales denominated in various...

•Global sales footprint with direct, distributor, and OEM channels
•Foreign sales are exposed to currency translation effects
•Material components and sub-assemblies are sourced from Mexico, China, and Malaysia
•International tenders and distributors are important to growth
•U.S. trade policy and tariffs can affect both supply chain and pricing

Masimo is focused on innovation in noninvasive monitoring, hospital automation, and remote care while using direct,...

Product innovation in monitoring and remote caremedium-term

Differentiated technology supports pricing power, clinical adoption, and long-term customer retention.

Channel expansion through OEMs and distributorsshort-term

Broader partner coverage increases market access and helps win large tenders and international accounts.

Infrastructure and capital investmentmedium-term

Capacity, systems, and operational infrastructure support growth and product commercialization.

Protect intellectual propertylong-term

IP protection helps defend technology differentiation and supports long-term monetization.

Masimo faces customer concentration risk, especially through a just-in-time distributor that represented 10% or more of...

high

Customer concentration through a key distributor

One just-in-time distributor represented 10% or more of consolidated revenue, so loss or disruption would materially reduce sales.

Scope: Distributor channel
Materiality: high

high

Tariffs and trade policy changes

Material components and sub-assemblies are sourced or manufactured outside the U.S., making costs and supply availability sensitive to trade actions.

Scope: Mexico, China, Malaysia sourcing
Materiality: high

medium

Foreign exchange volatility

Foreign sales denominated in various currencies can translate into lower U.S. dollar revenue when exchange rates move unfavorably.

Scope: International sales
Materiality: medium

medium

Regulatory and policy changes in healthcare

Changes in funding, staffing, trade, or regulatory policy can affect customer purchasing and product commercialization.

Scope: U.S. healthcare market
Materiality: medium

medium

IP litigation and defense costs

The company expects continued legal defense of intellectual property, which can be costly and uncertain.

Scope: Patent and trademark portfolio
Materiality: medium

Revenue recognition timing

Quarterly comparability and reported growth rates

Inventory valuation

Gross profit and cost of goods sold

Goodwill and intangible assets

Non-cash impairment charges and balance sheet values

Discontinued operations

Comparability of revenue, profit, and cash flow trends

Stock-based compensation and tax contingencies

SG&A, tax provision, and net income

Masimo Corp

Customer concentration through a key distributor

Tariffs and trade policy changes

Foreign exchange volatility

Regulatory and policy changes in healthcare

IP litigation and defense costs

VASO Corp

OSI SYSTEMS INC

MAXIMUS, INC.

MESA LABORATORIES INC /CO/

MYOMO, INC.

TELEFLEX INC